instrument control and data analysis software magellan tracker version 6.6 (Tecan Systems)
90
Structured Review
Tecan Systems
instrument control and data analysis software magellan tracker version 6.6
Instrument Control And Data Analysis Software Magellan Tracker Version 6.6, supplied by Tecan Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magellan+tracker+data+analysis+software/instrument+control+and+data+analysis+software+magellan+tracker+version+6+6/pm25736545-78-18-18
Average 90 stars, based on 1 article reviews
Instrument Control And Data Analysis Software Magellan Tracker Version 6.6, supplied by Tecan Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magellan+tracker+data+analysis+software/instrument+control+and+data+analysis+software+magellan+tracker+version+6+6/pm25736545-78-18-18
Average 90 stars, based on 1 article reviews
instrument control and data analysis software magellan tracker version 6.6 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Control:Article Title: Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy. Article Snippet: Results Thirty of 180 (16.7 %) patients with TED had DON of recent onset or a past history of DON (post-DON).. Optic disk swelling was present and visual-evoked potentials were pathologic in all eyes with DON of recent onset, but in one of 13 (7.7 %) with post-DON, only (p = 0.005).. 19/20 (96 %) patients with DON of recent onset were TSIpositive. Software:Article Title: Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy. Article Snippet: Results Thirty of 180 (16.7 %) patients with TED had DON of recent onset or a past history of DON (post-DON).. Optic disk swelling was present and visual-evoked potentials were pathologic in all eyes with DON of recent onset, but in one of 13 (7.7 %) with post-DON, only (p = 0.005).. 19/20 (96 %) patients with DON of recent onset were TSIpositive. |